USB CORPORATION – Trademark Portfolio

Entity Type: 03

USB CORPORATION owns a portfolio of 9 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), including well-known marks such as USB, PLISKA, PREPEASE, EXOSAP-IT, and HOTSTART-IT. Of these, 5 are registered. The portfolio spans 3 Nice Classification classes, led by Class 1 (Chemicals) and Class 33 (Wine & Spirits). Headquartered in CLEVELAND, OH.

26111 MILES RD

CLEVELAND, OH 44128

9 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

USB CORPORATION's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

1
Chemicals (4 filings)

Chemical products for industry, science, photography, agriculture, horticulture and forestry

33
Wine & Spirits (4 filings)

Alcoholic beverages (except beers)

5
Pharmaceuticals (3 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does USB CORPORATION have?

USB CORPORATION has 9 U.S. trademarks filed with the USPTO. Of these, 5 registered, 4 cancelled.

What trademark classes does USB CORPORATION file in?

USB CORPORATION files trademarks across 3 Nice Classification classes. The most active classes are Class 1 (Chemicals), Class 33 (Wine & Spirits), Class 5 (Pharmaceuticals). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.

What are USB CORPORATION's most well-known trademarks?

USB CORPORATION's registered trademark portfolio includes well-known marks such as USB, PLISKA, PREPEASE, EXOSAP-IT, and HOTSTART-IT. These are among 5 currently registered trademarks in the portfolio.

What is USB CORPORATION's trademark registration success rate?

USB CORPORATION has a 56% trademark registration rate, with 5 out of 9 resolved applications resulting in successful registration. Currently, 0 applications are pending review.